IL10 and in situ carcinoma: In the study by Guerrier, an imbalance in the cytokine production by circulating B cells, especially the alteration of IL-10 production with a high IL-6/IL-10-producing B-cell ratio, was associated with clinical conversion and its delay in a mixed cohort of CIS and RIS patients (31).